U.S. Markets closed
  • S&P 500

    4,136.48
    -43.28 (-1.04%)
     
  • Dow 30

    33,926.01
    -127.93 (-0.38%)
     
  • Nasdaq

    12,006.96
    -193.86 (-1.59%)
     
  • Russell 2000

    1,985.53
    -15.69 (-0.78%)
     
  • Crude Oil

    73.26
    -2.62 (-3.45%)
     
  • Gold

    1,878.70
    -52.10 (-2.70%)
     
  • Silver

    22.40
    -1.22 (-5.17%)
     
  • EUR/USD

    1.0804
    -0.0107 (-0.9831%)
     
  • 10-Yr Bond

    3.5320
    +0.1360 (+4.00%)
     
  • Vix

    18.33
    -0.40 (-2.14%)
     
  • GBP/USD

    1.2049
    -0.0180 (-1.4712%)
     
  • USD/JPY

    131.1850
    +2.5810 (+2.0069%)
     
  • BTC-USD

    23,388.38
    -384.33 (-1.62%)
     
  • CMC Crypto 200

    535.82
    -1.03 (-0.19%)
     
  • FTSE 100

    7,901.80
    +81.64 (+1.04%)
     
  • Nikkei 225

    27,509.46
    +107.41 (+0.39%)
     

This Investment Strategy Would Have Reduced Your Novavax Losses by 20% Last Year

This Investment Strategy Would Have Reduced Your Novavax Losses by 20% Last Year

To avoid that frustration, investors would do well to deploy a simplifying strategy for particularly risky investments. One such strategy that can help reduce your risk is dollar-cost averaging. If you had implemented this tactic when buying shares of Novavax (NASDAQ: NVAX) last year, it would have reduced your losses on the stock by 20%.